S. A. KESIKLI Et Al. , "The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus," European Congress of Immunology , vol.137, Glasgow, United Kingdom, pp.46-47, 2012
KESIKLI, S. A. Et Al. 2012. The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus. European Congress of Immunology , (Glasgow, United Kingdom), 46-47.
KESIKLI, S. A., Unluturk, U., GÜNAYDIN, G., Ates, C., Guc, D., Uysal, A. R., ... Emral, R.(2012). The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus . European Congress of Immunology (pp.46-47). Glasgow, United Kingdom
KESIKLI, S. Et Al. "The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus," European Congress of Immunology, Glasgow, United Kingdom, 2012
KESIKLI, S. A. Et Al. "The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus." European Congress of Immunology , Glasgow, United Kingdom, pp.46-47, 2012
KESIKLI, S. A. Et Al. (2012) . "The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus." European Congress of Immunology , Glasgow, United Kingdom, pp.46-47.
@conferencepaper{conferencepaper, author={S. A. KESIKLI Et Al. }, title={The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus}, congress name={European Congress of Immunology}, city={Glasgow}, country={United Kingdom}, year={2012}, pages={46-47} }